Latest Breaking News On - Prometic life sciences inc - Page 8 : vimarsana.com

Press release content from Business Wire. The AP news staff was not involved in its creation. Global Alpha 1 Antitrypsin Deficiency Treatment Market Report 2021-2027 - ResearchAndMarkets.com April 20, 2021 GMT DUBLIN (BUSINESS WIRE) Apr 20, 2021 Global Alpha 1 Antitrypsin Deficiency Treatment Market to Reach $2.9 Billion by 2027 Amid the COVID-19 crisis, the global market for Alpha 1 Antitrypsin Deficiency Treatment estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027. Augmentation Therapy, one of the segments analyzed in the report, is projected to record a 9.7% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bronchodilator segment is readjusted to a revised 9.4% CAGR for the next 7-year period.

United statesUnited kingdomUnited arab emiratesSaudi arabiaSouth koreaLaura woodKamada ltdGenetic technologies corporationOffice hours callArrowhead pharmaceuticals incBaxter international incBiogen incGrifols internationalTeva pharmaceutical industries ltdE st office hours callPfizer inc